Sigur冒ur Kristinsson, MD PhD
搁别测办箩补惫铆办,
Iceland
University of Iceland
Professor Sigur冒ur Yngvi Kristinsson is currently consolidating his position as one of the leading researchers world-wide in the field of multiple myeloma, its precursors, its epidemiology, progression, and treatment. This has been the main thrust of his scientific and clinical efforts from the time he defended his thesis on monoclonal gammopathies at the Karolinska Institutet in 2009. In 2012 he became the youngest full professor at the Faculty of Medicine at the University of Iceland and he is a consultant at Landspitali University Hospital. He designed and leads the largest myeloma screening study in the world, the iStopMM project in which over 80,000 individuals provided informed consent. His current research group includes 7 PhD-students, three postdocs, a lab with 4 biologists, 6 research nurses, three statisticians/data manager, and five support staff. He is an author of more than 110 scientific papers including the current guidelines for myeloma treatment and follow up and has an h-index of 57.
